Ethynodiol diacetateCAS号: 297-76-7分子式: C24H32O4分子量: 384.51描述纯度储存/保存方法别名外观可溶性/溶解性靶点In vitro(体外研究)In vivo(体内研究)
产品描述 | |
描述 |
Ethynodiol diacetate是第一批合成的避孕药用孕激素之一。去甲二氢愈创木酸(NDGA) (< 1.5 μM)在150 μg/mL ethynodiol diacetate处理的人淋巴细胞中可以降低姐妹染色单体的交换率(SCEs)。在S9混合物存在的情况下NDGA处理会减轻ethynodiol diacetate 引起的遗传毒性损伤,这可能是通过对细胞色素P450s的抑制实现的而P450s会阻止ethynodiol diacetate的代谢活化,也可能是由于 NDGA具有清除自由基的功能。在S9混合物存在的情况下, Ethynodiol diacetate (150 μg/mL)会增加人淋巴细胞中姐妹染色单体的交换率(SCEs)和染色体畸变(CAs)频率并能 抑制淋巴细胞增殖。 |
纯度 |
>98%
|
储存/保存方法 |
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
|
基本信息 | |
别名 |
双醋炔诺醇;Ethynodiol acetate
|
外观 |
白色粉末
|
可溶性/溶解性 |
DMSO :71 mg/mL (184.7 mM)
Water :71 mg/mL (184.7 mM) |
生物活性 | |
靶点 |
Progesterone receptor
|
In vitro(体外研究) |
Nordihydroguaiaretic acid (NDGA) ( Ethynodiol diacetate (150 μg/mL) increases sister chromatid exchanges (SCEs) and chromosomal aberrations (CAs) frequencies and inhibits lymphocyte proliferation in the presence of S9 mix in human lymphocyte.
|
In vivo(体内研究) |
Ethynodiol diacetate (6 mg/kg b.w. daily) significantly increases the amounts of excreted 3alpha-hydroxy-5alpha-pregnan-20-one and A-homo-3-oxa-5alpha-pregnane-4,20-dione in urine in female rats. Significant increase in the weights of pituitary, liver and kidneys are noted in rats treated with ethynodiol diacetate (6 mg/kg b.w. daily). Norgestrel (75 μg/day) and ethynodiol diacetate (150 μg/day), co-administered with ethinyl estradiol (7.5 μg/day), lowers the plasma concentrations of HDL cholesterol in cynomolgus monkeys.
|
分子结构图